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Orexins (OXA, OXB) are hypothalamic peptides playing crucial roles in arousal, feeding, social and 
reward-related behaviours. A recent study on juvenile rats suggested their involvement in vision 
modulation due to their direct action on dorsal lateral geniculate (dLGN) neurons. The present study 
aimed to verify whether a similar action of OXA can be observed in adulthood. Thus, in vivo and  
in vitro electrophysiological recordings on adult Wistar rats across light-dark and cortical cycles were 
conducted under urethane anaesthesia. OXA influenced ~28% of dLGN neurons recorded in vivo by 
either excitation or suppression of neuronal firing. OXA-responsive neurons did not show any spatial 
distribution nor represent a coherent group of dLGN cells, and responded to OXA similarly across the 
light–dark cycle. Interestingly, some OXA-responsive neurons worked in a cortical state-dependent 
manner, especially during the dark phase, and ‘preferred’ cortical activation over slow-wave activity 
induced by urethane. The corresponding patch clamp study confirmed these results by showing 
that < 20% of dLGN neurons were excited by OXA under both light regimes. The results suggest that 
oXA is involved in the development of the visual system rather than in visual processes and further 
implicate oXA in the mediation of circadian and arousal-related activity.
Orexin A and B (OXA and OXB), also known as hypocretin 1 and 2, are hypothalamic neuropeptides1,2 involved 
in diverse physiological functions such as feeding, regulation of the sleep-wake cycle, homeostasis, stress 
responses and motivation2–6. Derived from a common precursor prepro-orexin and synthetized exclusively in 
the lateral hypothalamus (LH), orexins bind to two G protein-coupled receptors: OX1 selective for OXA and 
non-selective OX2, binding both peptides with similar affinity2. Orexins exert their multiple effects by means of 
extensive projections throughout the brain1,7.
Engaged in the regulation of rhythmically occurring processes (e.g., sleep-wake cycle) and controlled by a 
master circadian pacemaker the suprachiasmatic nucleus (SCN)8–11, orexins follow a circadian pattern of expres-
sion and action. Significant daily variation has been found for the level of prepro-orexin mRNA and OXA immu-
noreactivity in the hypothalamus12–14, OXA in the cerebrospinal fluid9,10,15, as well as the number and activity of 
orexin neurons in rodents16,17. Increased levels of peptide production, expression and associated neuronal activity 
have been observed during the dark phase of the photoperiod, which in nocturnal rodents is a time of prolonged 
wakefulness and motor activity10,15,16. Indeed, orexin neurons increase their firing rate during active wakefulness, 
decrease the frequency of discharges when animals approach sleep and become silent during slow-wave and REM 
sleep18,19. Considered as a neuroexcitatory agent1,20–23, OXA has also been found to inhibit neuronal activity24,25. 
Interestingly, day/night differences have been reported for this mechanism of action in the SCN26.
Recently, an in vitro study showed that OXA exerts multiple excitatory actions on neurons in the dorsal lateral 
geniculate nucleus (dLGN), a thalamic relay for vision27. Therefore, this sensory modality has been suggested to 
be modulated by arousal and a circadian factor, both of which are related to orexins27. Certainly, visual process-
ing in the dLGN differs according to vigilance state28,29, and the neuronal activity of the dLGN has recently been 
reported to be influenced by the general state of the brain under different types of anaesthesia30,31.
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The present study aimed to investigate the putative action of OXA on neuronal activity in the dLGN in adult 
Wistar rats in vivo and in vitro. Considering the diurnal variation in the actions of orexins, as well as orexiner-
gic fibre density in the dLGN27, the peptide was applied in both phases of the photoperiod. Additionally, the 
light responsiveness, relationship with the general brain state, regularity of the discharge pattern and presence of 
infra-slow oscillatory activity of dLGN neurons were characterised.
Results
The recent patch clamp study on juvenile Wistar rats suggested orexin involvement in vision modulation due to 
the direct, excitatory action of orexins on dLGN neurons. Moreover, immunohistochemical staining showed 
sparse, circadially modulated orexinergic innervation in the dLGN27. We aimed to verify whether similar action 
of OXA can be observed in adulthood and, if so, whether it is influenced by the time of day. Therefore, we com-
pared sensitivity of dLGN neurons to OXA application during in vivo and in vitro recordings under two light 
regimes: light and dark (Fig. 1). The dLGN is known as the main thalamic relay centre for the visual pathway due 
to direct retinal innervation. Thus, the majority of recorded neurons were tested for light responsiveness. Quite 
recently it has been showed that neuronal activity within the dLGN is modulated by the general brain state30,31, 
accordingly, we aimed to describe OXA-responsive neurons also regarding this particular property. A subpopula-
tion of dLGN cells was previously found to express infra-slow oscillatory activity32–34; hence, we verified whether 
such neurons are influenced by OXA.
Figure 1. Experimental design. (a) The plan depicting the lighting conditions under which experiments 
were conducted. (b) A schematic drawing of the in vivo experimental design with examples of simultaneously 
recorded raw ECoG and neuronal activity signals and magnification of the recording electrode connected to 
the custom-made injection system enabling local, pressure-driven OXA infusions. (c) A schematic drawing of 
the in vitro experimental design with an example of a raw signal recorded from the dLGN (coloured red on the 
coronal slice).
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In total, the activity of 235 dLGN neurons was recorded in vivo under urethane anaesthesia: 118 under pho-
topic conditions during the light phase (100 µW/cm2, ZT 3–10; 25 rats) and 117 under scotopic conditions during 
the dark phase (>0.1 µW/cm2, ZT 15–22; 19 rats). The recorded neurons were evenly distributed across the entire 
dLGN, as shown in Fig. 2. Detailed electrophysiological characterization of all recorded neurons is presented in 
Supplementary Table S1, Figs S1, S2.
orexin A influences the spontaneous firing rate of dLGn neurons in vivo during the light 
phase. The effect of 200 µM OXA infusion on the spontaneous firing of dLGN neurons was first tested during 
the light phase. In total, 118 neurons were subjected to that experimental protocol; however, due to observed 
changes in the cortical state influencing the spontaneous firing rate of dLGN neurons during or just after OXA 
infusion (Fig. S1), only 106 neurons could be reliably analysed (100-s stabile baseline and 300-s post-infusion 
activity were compared). In 27 out of 106 dLGN cells, statistically significant changes (>3 SDs) in the firing 
rate were observed after pressure-driven OXA infusion, and both activation (n = 20) and suppression (n = 7) 
of firing were observed (Fig. 3). OXA-responsive neurons were further divided with respect to the cortical 
state during which they were tested; thus, four groups were characterised: activated (n = 16) and suppressed 
(n = 4) during slow-wave activity (SWA) and activated (n = 9) and suppressed (n = 4) during cortical activa-
tion. Importantly, Fisher’s exact test showed that there were no differences in the proportion of neurons respon-
sive to OXA between cortical phases (p = 1.00). OXA increased the spontaneous firing of dLGN neurons from 
3.09 ± 0.53 Hz to 5.67 ± 0.81 Hz (Wilcoxon matched-pairs signed rank test, p < 0.0001, W = 136.0; Fig. 3a,b) and 
9.49 ± 1.51 Hz to 13.96 ± 2.06 Hz (paired t-test two-tailed, p = 0.0031, t = 4.172, df = 8; Fig. 3d,e) during SWA 
and cortical activation, respectively. The change in firing rate (∆FR) upon OXA infusion was compared between 
cortical states to verify whether the magnitude of response is modulated by cortical alterations. A slightly higher 
∆FR was observed during cortical activation (Mann-Whitney test, two-tailed, p = 0.0953, U = 42.00; Fig. 3n). 
The mean response time upon OXA infusion did not differ between general brain states and was 118 ± 24 s and 
130 ± 39 s during SWA and cortical activation, respectively (OXA-activated neurons were compared: Wilcoxon 
matched-pairs signed rank test, p = 0.6523, W = −9.0; Fig. 3o). Surprisingly, a small subset of neurons was sup-
pressed by OXA application during the SWA (n = 4; Fig. 3g,h) and cortical activation (n = 4; Fig. 3j,k) states. 
Similarly as in the case of OXA-activated neurons, a higher ∆FR and longer response time were observed during 
cortical activation state, however the number of OXA-supressed neurons was too small to perform statistical 
comparison (Fig. 3p–r).
Figure 2. Localisation of in vivo recording sites. Estimated anatomical locations (based on the ChSB marks 
visualised under the microscope as shown on a representative image) of all recorded dLGN cells under the 
dark and light phase plotted on coronal diagrams (various distance from Bregma) from the stereotaxic rat 
brain atlas100. OXA-responsive neurons (colour-coded) in the dLGN were distributed across the structure. 
Dashed curves on the image outline the borders of the nuclei: dLGN – dorsal lateral geniculate nucleus, IGL – 
intergeniculate leaflet, vLGN – ventral latera geniculate nucleus.
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Figure 3. OXA influences spontaneous neuronal activity in the rat dLGN in vivo under the light phase. 
Representative traces of simultaneously recorded OXA-responsive dLGN neurons and ECoG presented 
as a delta-band ECoG power during (a, g) cortical SWA and (d, j) activation phases and adequate firing 
rate histograms of dLGN neurons (bin size = 1 s). Grey rectangles denote the time of OXA infusions. The 
mean ± SEM of OXA-activated neurons (whose firing rate was increased upon OXA infusion) recorded during 
cortical (b) SWA and (e) activation phases. The mean ± SEM coefficient of variation (CV) for ISI histograms 
were compared between neuronal activity before and after OXA infusion for OXA-activated neurons recorded 
during cortical (c) SWA and (f) activation phases. The mean ± SEM of OXA-supressed neurons (whose firing 
rate was decreased upon OXA infusion) recorded during cortical (h) SWA and (k) activation phases. The 
mean ± SEM coefficient of variation (CV) for ISI histograms were compared between neuronal activity before 
and after OXA infusion for OXA-supressed neurons recorded during cortical (i) SWA and (l) activation phases. 
(m) Summary of population data showing the proportion of OXA-responsive dLGN neurons recorded  
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Importantly, 13 out of 27 OXA-responsive neurons were tested under both cortical states, and five different 
response types were observed: activation (n = 5) or suppression (n = 1) under both phases, activation (n = 3) or 
suppression (n = 3) only during cortical activation and activation (n = 1) only under SWA state, suggesting that 
OXA at least to some extent works in a state-dependent manner and that alterations in the ECoG may influence 
dLGN neuron physiology, as the responses were often observed only during one cortical phase.
All neurons responsive to OXA (either activated or supressed) were characterised as non-regular with a mean 
CV of 1.20 ± 0.08 and 1.02 ± 0.04 during the SWA and cortical activation state, respectively, and their CV did 
not differ from the mean CV of neurons not responsive to OXA (unpaired t-test, two-tailed; SWA: p = 0.3376, 
t = 0.9561, df = 74; activation state: p = 0.3834, t = 0.8787, df = 55). Moreover, the mean CV was not changed 
during the response to OXA (SWA: Wilcoxon matched-pairs signed rank test, two-tailed, p = 0.3488, W = 52.00, 
n = 20; activation state: Paired t-test, two-tailed, p = 0.3485, t = 0.9757, df = 12, n = 13; Fig. 3c, f).
Electrophysiological characteristics of OXA-responsive dLGN neurons showed that 19 out of 23 tested neu-
rons were modulated by the cortical state (4 were only recorded during one cortical phase), 12 out of 26 tested 
were sensitive to light stimulation (light was presented mostly during SWA phase, however sometimes such ver-
ification was also performed during cortical activation state) and 8 exhibited both of these properties. Moreover, 
infra-slow oscillatory neurons (n = 3) were among these cells. Among OXA-responsive neurons receiving retinal 
input, all three known types35 of light responses were observed: transient ON (characterised by a peak of activity 
at the light onset and sometimes offset), OFF (exhibited a rebound activation after the stimulus termination) 
and sustained (maintained elevated firing during the stimulus presentation). The light-induced responses were 
assessed based on the peristimulus time histograms (bin size = 0.1 s) and 6 OXA-responsive neurons were char-
acterised as transient ON, 4 as transient OFF and 1 as sustained. Among OXA-activated neurons were transient 
ON, transient OFF, sustained and non-responsive types, while only 1 out of 7 OXA-supressed neurons was light 
responsive (transient OFF). Also, neurons responding to OXA application only during one cortical state could 
be characterised as transient ON, OFF or not light-responsive. The above analysis suggests that OXA-responsive 
dLGN neurons represent different neuronal populations, and only some of them (46%) are directly engaged in 
vision formation.
Background lighting does not influence dLGN cell responsiveness to OXA during the light 
phase. The dLGN receives strong excitatory input from retinal ganglion cells, which significantly influences 
its spontaneous activity36. Thus, we decided to verify whether a light background impacts the ability of dLGN 
cells to respond to OXA infusion. To this end, electrophysiological recordings were performed during the light 
phase under a photopic and scotopic lighting background. In total, 22 neurons were subjected to that protocol, 
and the response of each of them to OXA was tested four times (infusions during both cortical states under a 
photopic and scotopic background). OXA infusion statistically (≥3 SD) influenced the activity of 8 dLGN neu-
rons, and both activation (n = 4) and suppression (n = 4) of firing were observed. Among OXA-responsive cells, 3 
responded under all four conditions tested (2 cells were activated and 1 suppressed), and 5 responded only during 
the cortical activation state (2 cells were activated and 3 were suppressed). Importantly, there were no changes 
in cells responsiveness to OXA between background lighting conditions, meaning that if cells responded to the 
drug under scotopic conditions, they also responded under photopic conditions. In this way, we ruled out the 
possibility that a high firing rate of dLGN neurons under photopic conditions makes neurons insusceptible to 
OXA. Moreover, these observations confirm the above result suggesting that OXA may work in a state-dependent 
manner in the dLGN. Due to the small sample size, no statistical test could be performed; however, stronger sup-
pression of firing was observed under a photopic background, most likely due to the higher spontaneous firing 
rate (activation state: scotopic conditions, ∆FR: −7.15 ± 2.85 Hz, photopic conditions, ∆FR: −2.54 ± 0.95 Hz).
orexin A influences the spontaneous firing rate of dLGn neurons in vivo during the dark 
phase. Next, we set out to verify whether stronger orexinergic innervation of the dLGN during the dark 
phase is reflected in the electrophysiological sensitivity of these neurons to OXA infusion27. Thus, the effect of 
200 µM OXA pressure-driven infusion on the spontaneous firing of dLGN neurons was tested during the dark 
phase. In total, 117 cells were subjected to that experimental protocol; however, only 97 were further analysed. 
OXA infusion significantly influenced the spontaneous firing rate of 28% of tested dLGN neurons, and both acti-
vation (n = 14) and suppression (n = 14) of activity were observed (Fig. 4). The proportion of OXA-responsive 
neurons recorded during the lightening regimes did not differ (Fisher’s exact test, p = 0.6368); however, sup-
pression of activity upon OXA infusion was observed slightly more often during the dark phase (Fisher’s exact 
test, p = 0.0966). OXA-responsive dLGN neurons were further divided with respect to the cortical phase during 
which they were recorded, and four groups were characterised: activated (n = 4) or suppressed (n = 2) during 
SWA and activated (n = 12) or suppressed (n = 12) during cortical activation (Fig. 4). In contrast to the obser-
vations in the light phase, Fisher’s exact test showed that OXA-responsive neurons were more often found dur-
ing the cortical activation brain state. OXA infusion significantly increased dLGN firing from 3.35 ± 1.06 Hz to 
6.72 ± 1.36 Hz (Wilcoxon matched-pairs signed rank test, p = 0.0005, W = 78.00, n = 12, Fig. 4d,e) or decreased 
it from 13.39 ± 2.47 Hz to 6.01 ± 1.39 Hz (paired t-test two-tailed, p = 0.0074, t = 3.271; df = 11, n = 12, Fig. 4j,k). 
in vivo under the light phase (n = 106). (n, p) The change in firing rate (∆FR) ± SEM upon OXA application was 
compared between cortical states to verify whether the magnitude of response is modulated by general brain 
alterations. (o, q) The response time was also compared between OXA-responsive neurons and across cortical 
state. Data in (b,c,e,f,o,p and q) were analysed by Wilcoxon matched-pairs signed rank test and paired t-test, 
and data in (n) by Mann-Whitney test; ** p < 0.01, **** p < 0.0001, ns > 0.05.
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Figure 4. OXA influences spontaneous neuronal activity in the rat dLGN in vivo under the dark phase. 
Representative traces of simultaneously recorded OXA-responsive dLGN neurons and ECoG presented 
as a delta-band ECoG power during (a, g) cortical SWA and (d, j) activation phases and adequate firing 
rate histograms of dLGN neurons (bin size = 1 s). Grey rectangles denote the time of OXA infusions. The 
mean ± SEM of OXA-activated neurons (whose firing rate was increased upon OXA infusion) recorded during 
cortical (b) SWA and (e) activation phases. The mean ± SEM coefficient of variation (CV) for ISI histograms 
were compared between neuronal activity before and after OXA infusion for OXA-activated neurons recorded 
during cortical (c) SWA and (f) activation phases. The mean ± SEM of OXA-supressed neurons (whose firing 
rate was decreased upon OXA infusion) recorded during cortical (h) SWA and (k) activation phases. The 
mean ± SEM coefficient of variation (CV) for ISI histograms were compared between neuronal activity before 
and after OXA infusion for OXA-supressed neurons recorded during cortical (i) SWA and (l) activation phases. 
(m) Summary of population data showing the proportion of OXA-responsive dLGN neurons recorded in vivo 
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The mean response time did not differ between activated and suppressed neurons recorded under the cortical 
activation state and lasted 225 ± 59 s and 156 ± 32 s, respectively (Mann-Whitney test, p = 0.5041, U = 60.00, 
Fig. 4n). Importantly, 7 out of 28 OXA-responsive neurons were tested during both cortical states, and 2 of them 
were activated during both brain states, whereas the remaining 5 were influenced only during the cortical activa-
tion state (2 were activated and 3 were suppressed), further confirming that some OXA-responsive dLGN neurons 
work in a state-dependent manner.
The mean CV of OXA-responsive neurons was 1.23 ± 0.08 and 1.00 ± 0.02 during cortical SWA and acti-
vation states, respectively, and did not differ from that of neurons not responsive to OXA. Furthermore, OXA 
application did not influence the regularity of spiking in responding dLGN neurons (activation during cortical 
activation: paired t-test, two-tailed, p = 0.5988, t = 0.5418, df = 11, n = 12; suppression during cortical activation: 
Wilcoxon matched-pairs signed rank test, p = 0.1294, W = 40.00, n = 12; Fig. 4f, l).
Electrophysiologically, OXA-responsive neurons in the dark phase were, in the majority, modulated by the 
general brain state (20/22 tested) and received retinal innervation (17/28 from which 11 were characterised dur-
ing SWA phase and exhibited transient ON (n = 1), OFF (n = 3) and sustained (n = 6) responses). Moreover, 11 
of them expressed both of these properties. Similarly like in the light phase, responses to light could not be linked 
to any particular type of OXA-responding neurons, as transient ON, OFF and sustained responses were observed 
in activated and supressed neurons.
comparison between oXA-responsive dLGn neurons recorded in vivo under the light and dark 
period. Finally, we compared the electrophysiological properties of OXA-responsive dLGN neurons recorded 
during the light and dark periods. There were no differences in the magnitude of the response (calculated as the 
average change in ∆FR) and the mean time of the response between OXA-activated neurons (the response time: 
Mann-Whitney test, p = 0.0522, U = 84.5, Fig. 4o; magnitude of the response: Mann-Whitney test, p = 0.8911, 
U = 136.00, Fig. 4q) and OXA-supressed neurons (the response time: unpaired t-test two-tailed, p = 0.8779, 
t = 0.1557, df = 19; Fig. 4p; magnitude of the response: Mann-Whitney test, p = 0.4862, U = 39.00, Fig. 4r) 
recorded in vivo. Interestingly, significantly more neurons were influenced by OXA during cortical activation 
state in the dark phase than in the light phase (Fisher’s exact test, p < 0.0001).
Lack of circadian modulation in responsiveness to oXA of dLGn neurons recorded in vitro. 
Next, we turned our attention towards patch clamp recordings from dLGN slices obtained from adult rats to 
verify whether the differences observed between the presented results and Chrobok et al.27 were due to develop-
mental changes of the visual system, as the previous work was performed on juvenile Wistar rats.
In total, 50 neurons were recorded (25 neurons per phase). In both phases, responses to OXA application were 
observed, but were much more rare (8/50) than in juvenile rats27. During the light period, only 12% of recorded 
neurons were sensitive to OXA application, causing rather small depolarisation (Δmax: 0.60 ± 0.03 mV, n = 3/25, 
Fig. 5). In the dark period, 20% of recorded neurons were affected by OXA application, and a tendency for higher 
depolarisation was observed (Δmax: 2.03 ± 0.55 mV, n = 5/25, Fig. 5). Similar to in vivo preparations, there were 
no significant differences between the proportion of OXA-responsive dLGN neurons recorded during the light 
and dark period (Fisher’s exact test, p = 0.7019).
Sparse orexinergic innervation of the dLGn in juvenile rats. To verify whether the discrepancies 
between the presented results and Chrobok et al.27 were due to developmental changes in orexinergic innerva-
tion of the dLGN, an additional immunohistochemical experiment was performed. Using the same technique as 
Chrobok et al.27 we showed that the dLGN of juvenile rats is sparsely innervated by orexinergic fibres (mean area 
fraction: 0.096 ± 0.017; Fig. 6).
Discussion
To our knowledge, this is the first study showing that OXA causes long-lasting effects (excitation or inhibition; 
2–3 min long) in ~28% of dLGN neurons recorded in vivo under the light and dark phase, thus when neurons 
receive multiple neuronal inputs according to the Zeitgeber Time. OXA-responsive neurons did not show any 
spatial distribution and did not represent any coherent electrophysiological group of dLGN cells. Moreover, 
dLGN neurons responded to OXA similarly during the day and the night, as there were no differences in the 
magnitude of the response or the mean response time to OXA between light regimes. Interestingly, the present 
results show that OXA-responsive dLGN neurons can work in a state-dependent manner, especially during the 
dark phase, and ‘prefer’ cortical activation rather than the SWA state induced by urethane anaesthesia. Patch 
clamp recordings confirmed the results of the in vivo experiments and showed that <20% of dLGN neurons are 
excited by OXA under both light regimes. The magnitude of the response was slightly higher during the dark 
period, whereas the mean response time did not differ between phases and lasted ~3 min.
The effects of orexins on dLGN activity were studied before in slice preparation by three different 
groups27,37,38, and some inconsistencies were found. Reports by Bayer et al.23 and Govindaiah & Cox38 did not 
under the dark phase (n = 97). (n) The response time did not differ between activated and supressed neurons 
recorded during cortical activation state. Also, the response time did not differ between (o) activated and (p) 
supressed neurons recorded during light and dark phases. (q, r) The change in firing rate (∆FR) ± SEM upon 
OXA application was compared between lightening regimes to verify whether the magnitude of response is 
influenced by circadian time. Data in (e, k, l) were analysed by Wilcoxon matched-pairs signed rank test and 
paired t-test, and data in (n–r) by Mann-Whitney test and unpaired t-test; ** p < 0.01, *** p < 0.001, ns > 0.05.
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find any orexin-responsive neurons in the dLGN; however, they performed an overview of orexin action on 
different thalamic neurons. The total number of tested neurons in the dLGN in both studies was relatively low 
thus, orexin-responsive neurons may have been omitted from the recorded populations. On the other hand, 
Chrobok et al.27 focused on orexin action on the rat dLGN by performing a comprehensive study on Wistar rats. 
The authors showed that ~75% of dLGN neurons are excited by orexins regardless of light regime and with the 
involvement of voltage-dependent calcium influx and closure of GIRK channels. Moreover, their immunohisto-
chemical study revealed sparse orexinergic innervation of the dLGN with maximal fibre density during the dark 
period. The discrepancies between the high number of orexin-responsive neurons and the sparse orexinergic 
innervation of the dLGN were explained by a possible engagement of volume transmission. Interestingly, how-
ever, we hypothesised that this difference may be due to developmental changes, as they used juvenile (14–21 days 
old) and adult (5–6 weeks old) rats for electrophysiology and immunohistochemistry, respectively. Rodent retina 
and the visual system are developed at the time of eye-opening (P12–P14); however, the functionality of the retina 
and specificity of the retinogeniculate synapse take approximately three weeks spanning eye opening to display 
the activity and connectivity typical of adult animals39–43. In fact, the present study confirms this hypothesis by 
showing that a relatively lower proportion of dLGN neurons are sensitive to OXA in in vitro (~20%) and in vivo 
(~28%) preparations in adult rats. Notably, we used the same technique (patch clamp recordings) as Chrobok 
et al.27 to determine the effects of OXA on dLGN neurons in adult rats; therefore, the observed difference between 
the results is not due to technical issues. Thus, the next obvious question is whether the dLGN of juvenile rats is 
densely innervated by orexinergic fibres. Surprisingly, our immunohistochemical data showed sparse orexinergic 
innervation of the dLGN in immature rats at ZT 1–2. Moreover, the orexinergic innervation did not follow any 
spatial pattern explaining random distribution of OXA-responsive neurons in the dLGN in our in vivo study. In 
the work of Chrobok et al.27 the density of orexinergic fibres was slightly higher in the anterior direction, how-
ever we did not observed such pattern. The quantitative analysis showed that in the present work the mean area 
fraction of orexinergic fibres is a bit higher than in a previous work on adult animals. There are few explanations 
for that. First of all, confocal laser parameters during scanning are adjusted to the observed immunoreactiv-
ity, so some differences could appear there. Secondly, different parameters could be used in Bernsen’s adaptive 
thresholding method. Importantly, all previous studies examining orexinergic innervation of the brain showed 
dense orexinergic fibres in a wide range of brain areas but no or very low density in the dLGN44–46. The possible 
explanation for the discrepancies between sparse orexinergic innervation (the present data) and high sensitivity 
to OXs27 in the juvenile rat dLGN might be due to developmental changes in orexin receptors. In fact, remarkable 
differences in the mRNA levels of prepro-orexin and orexin receptors occur during the first weeks of the post-
natal period. Moreover, developmental changes are specific for brain regions. The mRNA level of prepro-orexin 
in the LH47,48, OXR1 in the ventromedial hypothalamic area and OXR2 in the paraventricular nucleus47 increases 
until the third postnatal week and then stabilises to further decrease with age. The hypothalamic level of mRNA 
for OXR1 and OXR2 has been shown to decrease with brain maturity, similar to the cortical level of OXR249,50. 
Moreover, OXR1 mRNA was present in the infant cerebellum but not detectable at all in maturity49. Similarly, 
expression of OXR2 mRNA in hypoglossal motoneurons peaks around P20 and then strongly decreases51. This 
difference in expression across development is not an unusual situation, as different peptide receptors, including 
those for vasopressin52 and somatostatin53, which are also present in the visual system54, have been found to 
be more strongly expressed in the developing than in the adult brain. As mentioned before, the dLGN changes 
remarkably during the first few weeks of the postnatal period, including changes in total RNA and DNA contents, 
Figure 5. Lack of circadian modulation in responsiveness to OXA of dLGN neurons recorded in vitro. 
Representative patch clamp recordings from dLGN neurons (yellow trace – recording from light phase, black 
trace – recording from dark phase) and their depolarizing responses to OXA (200 nM, green bar) application. 
Deflections represent voltage responses to rectangular pulses of current (80 pA). (b) The effect of OXA (200 nM) 
on the membrane potential of the dLGN neurons in ACSF in both phases (light and dark, respectively). Black 
dots and lines indicate neurons that were insensitive to peptide administration (non-responsive), and green dots 
and lines represent dLGN cells that were depolarised by OXA (responsive).
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which stabilises around P4055. Taking these rationales into account, we suggest that orexins may strongly influ-
ence dLGN postnatal development. Indeed, such a role for orexins in different brain regions has been suggested 
previously56. Alternatively, the low number of OXA-responsive neurons in the dLGN of adult animals may be 
connected to concentration-dependent activity of OXA57,58. In the present work concentrations of 200 nm and 
200 µm were used for patch clamp and in vivo studies, respectively. Even though, similar results were acquired for 
both preparations, there is still a possibility that higher concentrations would have more broaden responses. On 
the other hand, generally OXs concentration in nanomolar and micromolar range was used for the in vitro27,59–61 
and in vivo62–64 studies, respectively.
The present work shows that dLGN neurons may be excited or suppressed by OXA during in vivo recordings 
under urethane anaesthesia regardless of light regime. Importantly, urethane has already been proven to be a good 
anaesthetic for experiments investigating diurnal variations in electrophysiological recordings in the SCN65–67 
and medial habenula68. Additionally, urethane induces cyclic fluctuations in cortical and/or brainstem activity 
mimicking sleep episodes: slow-wave and desynchronization states; thus, urethane anaesthesia was used previ-
ously as a model of sleep (but not sleep-wake cycle)69–73. OXs are generally considered excitatory in both in vivo 
and in vitro preparations. Excitation of spontaneous neuronal activity by OXs has been observed under urethane 
anaesthesia in the hippocampus62, globus pallidus74, substantia nigra pars compacta63, dorsal raphe (DRN)75 and 
laterodorsal tegmental nucleus (LTD)64. Moreover, increases in neuronal activity in vitro upon OX application 
have been showed in numerous brain structures, such as the locus coeruleus76,77, tuberomammillary nucleus78, 
DRN79, intergeniculate leaflet59,80 and paraventricular nucleus of the thalamus61. However, an inhibitory action of 
OXA is not rare. OXA mainly suppresses neuronal firing in the SCN26,60,81,82 with different mechanisms across the 
light-dark cycle26. Moreover, OXA inhibits the activity of neurons expressing melanin-concentrating hormone 
in the LH by acting on local GABAergic interneurons83 and OX1R mRNA expression was found on the puta-
tive GABAergic interneurons in the LTD and pedunculopontine tegmental nuclei84. Additionally, hippocampal 
pyramidal neurons have been showed to be suppressed during in vivo recordings upon cerebral ventricle OXA 
Figure 6. Sparse orexinergic innervation of the dLGN in juvenile rats. A representative OXA 
immunofluorescent labelling of juvenile Wistar rat dLGN (green, right panel). Left panel represents pictures 
under bright light. The white bars represent 100 μm. Dashed curves on the images outline the borders of the 
nuclei: dLGN – dorsal lateral geniculate nucleus, IGL – intergeniculate leaflet and vLGN – ventral lateral 
geniculate nucleus.
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infusions by indirect activation of local inhibitory interneurons85. In line with these studies, our data show that 
OXA application in vivo can have a suppressive outcome on spike firing. Because we did not observe hyperpo-
larisation of dLGN neurons during patch clamp recordings, we speculate that the suppressive effect may be due 
to activation of local GABAergic interneurons. In fact, interneurons in the dLGN make inhibitory connections 
with relay cells86. In our in vivo recordings, OXA-suppressed neurons constituted 7% and 14% of all neurons 
recorded during light and dark phase, respectively. Distinction regarding a neuronal type: thalamo-cortical vs 
local interneurons in in vivo approach was not made, as even though general criteria exist for such analysis, it has 
not been published before specifically for the rat dLGN cells. Patch clamp recordings would enabled such dis-
crimination and experiment focusing on dLGN interneurons would help in interpretation of our data, however 
considering low percentage of interneurons in the dLGN (~10%), low response rate to OXA in the structure of 
adult rats and challenging methodological aspects regarding patch clamp recordings in adult animals, such exper-
iment would not seem to draw any conclusions. Importantly, local OXA infusion was not limited to the recorded 
neuron; thus, in some cases, we may have also observed transsynaptically mediated effects.
OXA-responsive dLGN neurons could not be linked to any specific population of dLGN neurons. Some of 
them (40% and 60% recorded under the light and dark phase, respectively) were sensitive to light stimulation and 
were thus most likely directly engaged in vision formation. The majority were modulated by the general brain state 
according to the simultaneously recorded ECoG under urethane anaesthesia. Moreover, OXA-responsive neu-
rons did not express the same firing pattern, as some of them were classified as infra-slow oscillatory during the 
light phase. Considering the large heterogeneity of dLGN neurons86, such a wide distribution of OXA-responsive 
neurons is not surprising. More importantly, these results extend those of Chrobok et al.27 by showing that OXA 
influences not only neurons contributing to direct vision formation but also dLGN neurons receiving signals 
from non-retinal inputs (for review see86). The very strong modulatory innervation of the dLGN derives from the 
brainstem cholinergic nuclei that control network states during arousal, sleep and wakefulness87,88. Interestingly, 
the present data show that some OXA-responsive dLGN neurons work in a state-dependent manner under ure-
thane anaesthesia. These OXA-responsive neurons were more often found during the dark period, and they ‘pre-
ferred’ cortical activation than SWA state. Orexinergic neurons promote arousal and are more active during 
wakefulness in the dark period and become silent during sleep18,19. During naturally occurring slow-wave sleep, 
thalamo-cortical dLGN neurons are mostly hyperpolarized and generate lower firing rates, whereas during REM 
sleep and waking states, they are depolarised and fire more often89,90. Moreover, neurons switch between bursting 
and tonic firing modes, with the latter prevailing during slow-wave sleep91–93. These differences reflecting the 
state-dependence of dLGN neuron physiology have been examined in detail in terms of their light responsive-
ness94–97 and with little attention to the state-modulatory influences of pharmacological agent application89,98. 
Iontophoretical administration of acetylcholine to single dLGN cells caused excitation of firing only during wak-
ing and REM sleep89, whereas adrenergic receptor agonists worked mainly during slow-wave sleep98. On the 
other hand, OXA was showed to work in a state-dependent manner on the serotoninergic DRN neurons causing 
excitation only during naturally occurring sleep75. Our results coincide well with these studies, as we report that 
state-dependent OXA-responsive dLGN neurons responded during the cortical activation state and were more 
often observed during the dark period. These neurons were mostly modulated by the ECoG and were character-
ised by a higher firing rate during cortical activation than during SWA state. We hypothesise that state-dependent 
OXA-responsive dLGN neurons may be engaged in mediating arousal-related activity, however taking into con-
sideration the heterogeneous nature of the dLGN and small number of such neurons; it may be difficult to test.
Three main conclusions can be driven from the present study. First, taking into consideration the relatively 
low number of OXA-responsive dLGN neurons recorded in vivo and in vitro in adult rats compared to previously 
published data on juvenile rats27 and sparse orexinergic innervation of the nucleus in both studies, we suggest 
that OXA is particularly important for the postnatal development of the visual thalamus. At present, however, its 
role in this process remains unclear and requires further investigation. Second, a comprehensive analysis of the 
electrophysiological properties of OXA-responsive dLGN neurons showed a large heterogeneity, thus extending 
its previously suggested role from modulation of visual processes to more global effects on dLGN functioning. 
OXA-responsive neurons were characterised as receiving not only visual information but also modulatory influ-
ences from the brainstem and/or cortex. Moreover, the state-dependent action of OXA, intensified during the 
dark period, further implicates its contribution to the mediation of circadian and arousal-related activity to the 
dLGN, which may result in the facilitation/attenuation of incoming information and/or information processed 
by the dLGN. Lastly, we emphasise the importance of circadian control of not only clock-related structures and 
simultaneous ECoG and spike recordings, especially in experiments on the thalamus.
Methods
ethical approval. All experimental procedures were performed in accordance with Polish Animal Protection 
Law, approval (196/2012) of Local Ethics Committee of Jagiellonian University in Krakow and regulations and 
standards of the Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 
on the protection of animals used for scientific purposes, the 3Rs law, and the ARRIVE guidelines for reporting 
experiments involving living animals with respect to anaesthesia and animal handling99.
Animals. All experiments, except for the immunohistochemistry study, were conducted on adult, male Wistar 
rats bred in the animal facility of the Institute of Zoology and Biomedical Research at Jagiellonian University in 
Krakow. Animals were housed under a 12:12-h light:dark cycle at a temperature of 22–23 °C and 60% humid-
ity with food and water available ad libitum. Zeitgeber time (ZT) 0 was designated as the time of lights on. 
Experiments were performed during two different light regimes: light phase (ZT 1–11) and dark phase (ZT 
13–23). Regardless of the experimental protocol (in vivo or in vitro study), animals were removed from their 
home cages during the early portion of the light (ZT 1–2) or dark (ZT 13–14) phase. For in vivo experiments, 
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rats were directly anaesthetised with an i.p. injection of urethane (1.5 g/kg in 2 mL of 0.9% NaCl, Sigma-Aldrich, 
Poland). The dark phase group received the injection in a darkened room, and immediately after their eyes were 
covered with black foil. The surgery and electrophysiological recordings were performed in a darkened room with 
the light intensity at the animal’s eyes < 0.1 µW/cm2 through the experimental sessions. The rig was covered with a 
light-impermeable material. Electrophysiological experiments during the light phase were conducted in the same 
experimental room with room lights on (~100 µW/cm2). The electrophysiological recordings spanned the middle 
portion of the light (ZT 3–10) and dark (ZT 15–22) phases. The experimental design is shown in Fig. 1. A total 
of 64 rats were used for the study (47 for in vivo, 13 for in vitro and 4 for immunohistochemistry experiments).
In vivo neurophysiology. Surgery and single-unit electrophysiological recordings. Adult Wistar rats weigh-
ing 270–400 g (2–3 months old) were used. Following urethane injection and prior to the surgery, each animal 
was checked for withdrawal and ocular reflexes to assess the level of anaesthesia (additionally supplemented with 
10% of the initial dose of urethane, if necessary). The physiological state of the animal was continuously moni-
tored by electrocardiogram and body temperature readouts. The animals’ head was secured in a stereotaxic appa-
ratus (Advanced Stereotaxic Instruments, USA) and an initial incision was made to expose the scull surface. Skin 
and all soft tissues were removed to reveal sutures and stereotaxic points. A craniotomy was performed above the 
dLGN, 4–5 mm posterior and 3.3–4.3 mm lateral to bregma100. The dura was punctured, and the exposed brain 
tissue was covered with a drop of mineral oil (Sigma-Aldrich, Poland) to prevent drying. The recordings were 
taken at a depth of 4.0–5.5 mm from the first contact of the electrode with the cortical surface. Borosilicate glass 
micropipettes (resistance: 5–10 MΩ) pulled on a horizontal puller (P-97; Sutter Instrument Co., USA) and filled 
with 4% Chicago Sky Blue in 2% NaCl (ChSB; Sigma–Aldrich, Poland) were used to acquire neuronal signals. 
The recorded single-unit (sometimes multi-unit) activity was amplified 10,000 × , filtered between 300 Hz and 
3 kHz and digitised at 20 kHz using an Axon Instruments CyberAmp 380 (Molecular Devices Corporation, USA), 
Figure 7. Control experiment involving saline pressure-driven infusion into the dLGN. (a) Delta-band 
ECoG power calculated from the raw ECoG trace and simultaneously acquired (b) raw neuronal signal from 
the dLGN. (c) The typical waveforms of extracellularly recorded dLGN neurons are visible on an expanded 
timescale, thereby allowing spike sorting (green, red and blue vertical lines below the raw trace in (b). (d) A 
firing rate histogram (bin size = 1 s) constructed for unite 1 (blue). (e) After spike extraction, waveforms were 
clustered and sorted into three units based on principal component analysis (PCA). (f) Distribution histograms 
of interspike intervals (ISIs) for all three sorted units confirming proper spike sorting. (g) The mean ± SEM 
firing rate for baseline and after saline infusion. Data were analysed by paired t-test, ns > 0.05.
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Micro mkII interface and Spike2 software (version: 7.10; Cambridge Electronic Design Inc., UK). Data were 
stored on a computer, and all further analyses were performed off-line.
Local drug infusions. The recording electrode was connected to a custom-made injection system enabling 
local, pressure-driven drug infusions (Fig. 1b). The injection system was built using a fused silica capillary tube 
(100 µm ID, 164 µm OD; Polymicro Technologies; www.molex.com, cat no. TSP100170) glued to the Tygon tube 
and connected to a 5-µL Hamilton syringe (Sigma-Aldrich, Poland). Next, the fused silica tube was glued 200–
300 µm above the tip of the recording electrode under visual microscopic control. The same system was used 3 
to 4 times and was tested for leaks and washed out with sterilized water each time. The system was pre-loaded 
with 200 µM OXA diluted in saline or saline and 200 nL of the fluid was infused. In control experiments (n = 14 
neurons recorded during light phase and cortical SWA from 3 animals), 200 nL of saline was slowly infused dur-
ing on-line monitoring cell activity to confirm outflow, signal stability and lack of cell response. There were no 
significant differences between the mean firing rate or CV before and after saline infusion (Fig. 7). The system was 
built based on Cerina et al.101.
Electrocorticogram (ECoG) recordings. ECoG was simultaneously recorded with neuronal activity using 
a silver-wire electrode mounted on the stainless-steel screw contralateral to the recording site. The signal was 
amplified 1,000x and bandpass filtered between 0.5–30 Hz using a CyberAmp 380 amplifier equipped with a pre-
amplifier (Axon Instruments, USA) and connected to CED Micro mkII interface and Spike2 software (version: 
7.10; Cambridge Electronic Design Inc., UK).
Light stimulations. The majority of recorded cells were tested for light responsiveness. Light stimulations 
were mostly presented during cortical activation phase (it is longer and more stable under urethane anaesthesia). 
Thus, the eye contralateral to the craniotomy (dLGN cells exhibited pure contralateral or binocular responses 
to light stimulations102,103) was held open, and the pupil was dilated by a topical application of atropine solution 
(Atropinum Sulfuricum WZF 1%, Polfa, Poland). The cornea was moisturized with mineral oil to prevent drying. 
A light-emitting diode (white, cold LED; 5 mm; OptoSupply Ltd., China; OSWWY25111E) was placed in front of 
the eye and connected to a Master-8 stimulator (A.M.P.I., Israel). Regardless of the experimental group (light or 
dark phase), all animals were presented with 5-s light pulses with 25-s intervals, repeated 6–8 times. The intensity 
of the light stimulus differed, as it was presented against photopic and scotopic backgrounds, and was 220 and 
100 µW/cm2 for the light and dark group, respectively. The light intensity was measured with a GENTEC P-LINK 
(Gentec Electro-Optics, Canada).
Histological verifications. To mark the recording sites, at the end of each experiment, an anodal current (20 
μA) was ejected for 15 min from the recording electrode containing ChSB (Fig. 2). Next, rats were overdosed with 
sodium-pentobarbital (Biovet, Poland) and subsequently intracardially perfused with 0.1 M phosphate-buffered 
saline (PBS) and 4% paraformaldehyde (PFA) in PBS (pH = 7.4). Brains were removed and post-fixed in PFA for 
~48 h. Coronal slices (100 μm thick) were cut on a vibroslicer (Leica VT1000S, Germany), and all sequential sec-
tions containing the dLGN were collected. ChSB marks were verified with a light microscope and mapped onto 
corresponding coronal schemes of the stereotactic atlas of the rat brain100.
Data analysis. Waveforms extracted from the continuous signal were sorted off-line using the template 
matching method and principal component analysis (PCA; Fig. 7) in Spike2 software (version: 7.10; Cambridge 
Electronic Design, Inc., UK). Moreover, proper spike sorting was confirmed by interspike interval (ISI) 
histograms.
Simultaneously recorded alternating changes in ECoG signal: cortical SWA and activation states were iden-
tified based on the work of Clement et al.69 and were characterised by a dominant frequency, delta (~1 Hz) and 
theta (~4 Hz), respectively.
The relationship between the firing rate of a single dLGN neuron and ECoG changes was established as in31. 
Briefly, a cross-correlation coefficient (CC) analysis was performed on delta power band derived from ECoG sig-
nals containing both activated and SWA phases (at least one alteration in ECoG) and simultaneously recorded FR 
of the dLGN neurons. Neurons were characterised as significantly correlated with the ECoG when their maximal 
CC values exceeded confidence limits representing a 2-fold increase in their respective standard errors. Based on 
maximal CC values, dLGN neurons were classified into SWA-ON and activation-ON (Supplementary Fig. S1 and 
Table S1). Cross-correlation analysis was performed using Statistica software (StatSoft, Inc., USA).
dLGN neurons were classified as light responsive based on the peristimulus time histograms (PSTHs, bin 
size = 0.1 s, Supplementary Fig. S1) calculated in Spike 2 software (version: 7.10; Cambridge Electronic Design, 
Inc., UK).
The regularity of firing was assessed based on the coefficient of variation (CV) calculated as a ratio of the SD 
of the ISI to its mean. The Young’s regularity criterion was used104, and neurons in which CVs exceeded 0.35 were 
classified as non-regular.
The infra-slow oscillatory activity was identified by applying fast Fourier transform and autocorrelation anal-
ysis to ~900-s-long intervals, as shown before in detail105.
To characterise dLGN neurons as OXA-responsive, we used a similar method as Chen et al.62. The baseline fir-
ing rate was averaged for at least 50 s (max 200 s when examining infra-slow oscillatory pattern of activity) before 
OXA application with the condition that the recording had to be obtained under one cortical phase. To assess the 
beginning and end of the response to OXA, the firing rate was averaged for 10-s bins with a 1-s sliding window 
starting from 10 s before OXA infusion (the averaged firing rate of the first second starting from the beginning 
of infusion was calculated as the averaged firing rate of 9 s before and the 1 s from the beginning of the infusion). 
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An increase or decrease in firing rate was considered significant if it exceeded or fell below 3 standard deviations 
(SDs). The SD was calculated by averaging the firing rate of sequential time bins (10 s) within 50 s before OXA 
application.
Statistical comparisons were based on the results of two-way ANOVA followed by Tukey’s test, paired/
unpaired t tests, Mann–Whitney, Kruskal–Wallis, Wilcoxon tests, Fisher’s and Chi-square exact tests performed 
in Prism, version 5 (GraphPad Software Inc., USA). Significance was set at p < 0.05. Data are presented as the 
mean ± SEM.
patch clamp recordings. Tissue. To obtain brain slices containing the dLGN, we used a previously 
described procedure59. In short, adult male Wistar rats (5–6 weeks old) were anaesthetised with isoflurane (2 ml/
kg body weight; Baxter, Poland) and decapitated between ZT 1–2 or ZT 13–14. Next, the brain was quickly 
removed and immersed in ice-cold, oxygenated (carbogen, 95% O2, 5% CO2) cutting artificial cerebrospinal 
fluid (ACSF), composed of (in mM) 185 sucrose, 25 NaHCO3, 3 KCl, 1.2 NaH2PO4, 2 CaCl2, 10 MgCl2 and 10 
glucose. Then, the block of brain tissue containing the thalamus was placed on the cold plate of the vibroslicer 
(Leica VT1000S, Germany). Coronal slices, 250 µm in thickness, including the dLGN, were cut and transferred 
to the pre-incubation chamber filled with recording ACSF containing (in mM) 123 NaCl, 25 NaHCO3, 3 KCl, 
1.2 NaH2PO4, 2 CaCl2, 2 MgCl2 and 10 glucose. Slices were kept in this solution for 30 min at 32 °C, followed by 
60 min at room temperature before placement in the recording chamber (21 °C–24 °C).
Whole-cell recordings. Recording electrodes were placed in the dLGN under visual microscopic control 
(40× objective of a Zeiss Examiner microscope fitted with infrared differential interference contrast (Germany). 
Recordings were performed in whole-cell configuration obtained by applying negative pressure from an 
Ez-gSEAL100B Pressure Controller (Neo Biosystem, USA). The recorded signal was amplified by a SC 05LX 
amplifier (NPI, Germany), low-pass filtered at 3 kHz and digitized at 20 kHz. Spike2 and Signal (Cambridge 
Electronic Design, Inc., UK) software were used for the recordings. A liquid junction potential of approximately 
−13 mV was added to the measured membrane potential. Typical recordings lasted ~1000 s.
Experiments in current clamp mode (holding current = 0 pA) were conducted at room temperature 
(21 °C–24 °C). Patch pipettes pulled on a horizontal puller (P-97; Sutter Instrument Co., USA) were filled with 
normal intrapipette solution containing (in mM) 125 potassium gluconate, 20 KCl, 10 HEPES, 2 MgCl2, 4 
Na2ATP, 0.4 Na3GTP, 1 EGTA and 0.05% biocytin (pH = 7.4 adjusted with 5 M KOH; osmolarity ~ 300 mOs-
mol/kg). Rectangular current pulses (1 s, 80 pA) were applied to monitor the membrane resistance during each 
recording. Neurons for which the membrane resistance changed by more than 15% during the recording or that 
had a membrane potential more positive than −35 mV (−50 mV when adjusted for the junction potential) were 
excluded from further analysis.
Data analysis. All data were analysed using MATLAB (MathWorks, Inc., USA) and GraphPad Prism 6 
(GraphPad Software, Inc., USA) software. Changes in the firing rate and membrane potential were considered to 
be significant if they differed from baseline by more than three standard deviations (SDs). Data are presented as 
the mean ± SEM or maximal change of membrane potential ± SEM (Δmax). Δmax is described as the highest point 
of the examined value reached during the response.
Drugs. OXA (Tocris, Bristol, UK) was freshly prepared from 200 µM stocks (dissolved in saline), and 200 µM 
or 200 nM was used for the in vivo or in vitro study, respectively.
Immunohistochemistry - OXA fibres. Four male juvenile Wistar rats (14–21 days old) were deeply anaes-
thetised with pentobarbital (100 mg/kg, i.p.) and sacrificed (ZT 1–2) by transcardial perfusion with PBS followed 
by 4% PFA. Brains were quickly removed and immersed in 4% PFA overnight. Next, blocks of tissue containing 
the dLGN were cut into 100- µm-thick slices on a vibroslicer (Leica VT1000S, Germany) and rinsed twice in 
PBS. Then, slices were transferred to solution containing 0.6% Triton X-100 (Sigma-Aldrich, Poland) and 10% 
NDS (Jackson ImmunoResearch Europe Ltd., UK) at room temperature. After 2 h, slices were rinsed in fresh 
PBS and incubated with goat OXA antisera (1:200, Santa Cruz Biotechnology, USA) in PBS, 2% NDS and 0.3% 
Triton X-100 overnight at 4 °C. Next, slices were washed twice in PBS and incubated with secondary anti-goat 
AlexaFluor 488-conjugated antibodies (1:300; Jackson ImmunoResearch Europe Ltd., UK) for 24 h. Finally, slices 
were rinsed in PBS and mounted on glass slides in FluoroshieldTM (Sigma-Aldrich, Poland). Slices were then 
scanned on an A1-Si Nikon Inc. (Japan) confocal laser scanning system built on an inverted Nikon Ti-E micro-
scope (Japan). Image processing was performed with the use of ImageJ2 software (version: 2.0.0-rc41/1.50d, NIH, 
USA). Quantitative analysis of the orexinergic fibres was performed using similar protocol to Chrobok et al.27 
and the whole area of the dLGN was scanned. The results are presented as area fraction (%) ± SEM (total sum of 
immunoreactive pixels divided by the area of the dLGN).
Data availability
The datasets generated and analysed during the current study are available from the corresponding authors on 
reasonable request.
Received: 24 June 2019; Accepted: 21 October 2019;
Published: xx xx xxxx
1 4Scientific RepoRtS |         (2019) 9:16729  | https://doi.org/10.1038/s41598-019-53012-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
References
 1. de Lecea, L. et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95, 
322–7 (1998).
 2. Sakurai, T. et al. Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that 
Regulate Feeding Behavior. Cell 92, 573–585 (1998).
 3. Sakurai, T. The neural circuit of orexin (hypocretin): Maintaining sleep and wakefulness. Nat. Rev. Neurosci. 8, 171–181 (2007).
 4. Inutsuka, A. & Yamanaka, A. The regulation of sleep and wakefulness by the hypothalamic neuropeptide orexin/hypocretin. 
Nagoya J. Med. Sci. 75, 29–36 (2013).
 5. Burdakov, D. Reactive and predictive homeostasis: Roles of orexin/hypocretin neurons. Neuropharmacology 0–1 https://doi.
org/10.1016/j.neuropharm.2018.10.024 (2018).
 6. Sargin, D. The role of the orexin system in stress response. Neuropharmacology 0–1 https://doi.org/10.1016/j.
neuropharm.2018.09.034 (2018).
 7. Nambu, T. et al. Distribution of orexin neurons in the adult rat brain. Brain Res. 827, 243–260 (1999).
 8. Abrahamson, E. E., Leak, R. K. & Moore, R. Y. The suprachiasmatic nucleus projects to posterior hypothalamic arousal. Neuroreport 
12, 435–440 (2001).
 9. Deboer, T. et al. Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience 129, 727–732 (2004).
 10. Zhang, S. et al. Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release. Sleep 27, 619–627 (2004).
 11. Deurveilher, S. & Semba, K. Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: 
Implications for the circadian control of behavioural state. Neuroscience 130, 165–183 (2005).
 12. Taheri, S. et al. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. 
Neurosci. Lett. 279, 109–112 (2002).
 13. Yoshida, Y. et al. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-
wake activities. Eur. J. Neurosci. 14, 1075–1081 (2001).
 14. Justinussen, J. L., Holm, a & Kornum, B. R. An optimized method for measuring hypocretin-1 peptide in the mouse brain reveals 
differential circadian regulation of hypocretin-1 levels rostral and caudal to the hypothalamus. Neuroscience 310, 354–361 (2015).
 15. Fujiki, N. et al. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. 
Neuroreport 12, 993–997 (2001).
 16. Estabrooke, I. V. et al. Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21, 1656–62 (2001).
 17. McGregor, R., Shan, L., Wu, M. F. & Siegel, J. M. Diurnal fluctuation in the number of hypocretin/orexin and histamine producing: 
Implication for understanding and treating neuronal loss. PLoS One 12, 1–16 (2017).
 18. Lee, M. G. Discharge of Identified Orexin/Hypocretin Neurons across the Sleep-Waking Cycle. J. Neurosci. 25, 6716–6720 (2005).
 19. Mileykovskiy, B. Y., Kiyashchenko, L. I. & Siegel, J. M. Behavioral correlates of activity in identified hypocretin/orexin neurons. 
Neuron 46, 787–798 (2005).
 20. Eriksson, K. S., Sergeeva, O., Brown, R. E. & Haas, H. L. Orexin/hypocretin excites the histaminergic neurons of the 
tuberomammillary nucleus. J. Neurosci. 21, 9273–9 (2001).
 21. Follwell, M. J. & Ferguson, A. V. Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus. 
J. Physiol. 545, 855–867 (2002).
 22. Liu, R., Pol, A. N., Den, V. & Aghajanian, G. K. Hcrt and serotoninHypocretins (orexins) regulate serotonin neurons in the dorsal 
raphe nucleus by excitatory direct and inhibitory indirect actions. 22, 9453–9464 (2002).
 23. Bisetti, a et al. Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 142, 999–1004 
(2006).
 24. Sakhi, K. et al. Intrinsic and extrinsic cues regulate the daily profile of mouse lateral habenula neuronal activity. J. Physiol. 592, 
5025–5045 (2014).
 25. Gaskins, G. T. & Moenter, S. M. Orexin A suppresses gonadotropin-releasing hormone (GnRH) neuron activity in the mouse. 
Endocrinology 153, 3850–3860 (2012).
 26. Belle, M. D. C. & Piggins, H. D. Circadian regulation of mouse suprachiasmatic nuclei neuronal states shapes responses to orexin. 
Eur. J. Neurosci. 45, 723–732 (2017).
 27. Chrobok, L., Palus-Chramiec, K., Chrzanowska, A., Kepczynski, M. & Lewandowski, M. H. Multiple excitatory actions of orexins 
upon thalamo-cortical neurons in dorsal lateral geniculate nucleus - implications for vision modulation by arousal. Sci. Rep. 7, 1–16 
(2017).
 28. Coenen, A. M. L. & Vendrik, A. J. H. Determination of the transfer ratio of cat’s geniculate neurons through quasi-intracellular 
recordings and the relation with the level of alertness. Exp. Brain Res. 14, 227–242 (1972).
 29. Livingstone, M. & Hubel, D. Effects of sleep and arousal on the processing of visual information in the cat. Nature, 291(5816), 554-
561. 291, 554–561 (1981).
 30. Pietersen, A. N. J. et al. Relationship between cortical state and spiking activity in lateral geniculate nucleus of anaesthetised 
marmosets. J. Physiol. 595, 4475–4492 (2017).
 31. Jeczmien-Lazur, J. S., Orlowska-Feuer, P., Smyk, M. K. & Lewandowski, M. H. Modulation of spontaneous and light-induced 
activity in the rat dorsal lateral geniculate nucleus by general brain state alterations under urethane anaesthesia. Neuroscience 413, 
279–293 (2019).
 32. Chrobok, L., Palus-Chramiec, K., Jeczmien-Lazur, J. S., Blasiak, T. & Lewandowski, M. H. Gamma and infra-slow oscillations 
shape neuronal firing in the rat subcortical visual system. J. Physiol. 11, 2229–2250 (2018).
 33. Filippov, I. V. & Frolov, V. A. Very slow potentials in the lateral geniculate complex and primary visual cortex during different 
illumination changes in freely moving rats. Neurosci. Lett. 373, 51–6 (2005).
 34. Albrecht, D., Royl, G. & Kaneoke, Y. Very slow oscillatory activities in lateral geniculate neurons of freely moving and anesthetized 
rats. Neurosci. Res. 32, 209–220 (1998).
 35. Brown, T. M. et al. Melanopsin contributions to irradiance coding in the thalamo-cortical visual system. PLoS Biol. 8, (2010).
 36. Storchi, R. et al. Melanopsin-driven increases in maintained activity enhance thalamic visual response reliability across a simulated 
dawn. Proc. Natl. Acad. Sci. USA 112, E5734–43 (2015).
 37. Bayer, L. et al. Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J. Neurosci. 22, 7835–9 
(2002).
 38. Govindaiah, G. & Cox, C. L. Modulation of thalamic neuron excitability by orexins. Neuropharmacology 51, 414–425 (2006).
 39. Hong, Y. K. et al. Refinement of the Retinogeniculate Synapse by Bouton Clustering. Neuron 84, 332–339 (2014).
 40. Hong, Y. K. & Chen, C. Wiring and rewiring of the retinogeniculate synapse. Curr. Opin. Neurobiol. 21, 228–237 (2011).
 41. Chen, C. & Regehr, W. G. Developmental Remodeling of the Retinogeniculate Synapse. Neuron 28, 955–966 (2000).
 42. Hooks, B. M. & Chen, C. Distinct Roles for Spontaneous and Visual Activity in Remodeling of the Retinogeniculate Synapse. 
Neuron 52, 281–291 (2006).
 43. Nadal-Nicolás, F. M., Vidal-Sanz, M. & Agudo-Barriuso, M. The aging rat retina: from function to anatomy. Neurobiol. Aging 61, 
146–168 (2018).
 44. Baldo, Ba, Daniel, Ra, Berridge, C. W. & Kelley, A. E. Overlapping distributions of orexin/hypocretin- and dopamine-β-hydroxylase 
immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J. Comp. Neurol. 464, 220–237 (2003).
1 5Scientific RepoRtS |         (2019) 9:16729  | https://doi.org/10.1038/s41598-019-53012-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
 45. Nixon, J. P. & Smale, L. A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and 
diurnal rodents. Behav. Brain Funct. 3, 1–27 (2007).
 46. Kilduff, T. S. et al. Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems. J. Neurosci. 18, 9996–10015 
(2018).
 47. Yamamoto, Y. et al. Postnatal development of orexin/hypocretin in rats. Mol. Brain Res. 78, 108–119 (2000).
 48. Sawai, N., Ueta, Y., Nakazato, M. & Ozawa, H. Developmental and aging change of orexin-A and -B immunoreactive neurons in 
the male rat hypothalamus. Neurosci. Lett. 468, 51–55 (2010).
 49. Van Den Pol, A. N., Patrylo, P. R., Ghosh, P. K. & Gao, X. B. Lateral hypothalamus: Early developmental expression and response 
to hypocretin (orexin). J. Comp. Neurol. 433, 349–363 (2001).
 50. Iwasa, T. et al. Developmental changes in the hypothalamic mRNA levels of prepro-orexin and orexin receptors and their sensitivity 
to fasting in male and female rats. Int. J. Dev. Neurosci. 46, 51–54 (2015).
 51. Volgin, D. V., Saghir, M. & Kubin, L. Developmental changes in the orexin 2 receptor mRNA in hypoglossal motoneurons. 
Neuroreport 13, 433–436 (2002).
 52. Tribollet, E., Goumaz, M., Raggenbass, M., Dubois-Dauphin, M. & MichelDreifuss, J. J. Early appearance and transient expression 
of vasopressin receptors in the brain of rat fetus and infant. An autoradiographical and electrophysiological study. Dev. Brain Res. 
58, 13–24 (1991).
 53. Theveniau, M. & Reisine, T. Developmental Changes in Expression of a 60 kDa Somatostatin Receptor Immunoreactivity in the 
Rat Brain. J. Neurochem. 60, 1870–1875 (1993).
 54. Bodenant, C., Leroux, P., Gonzalez, B. J. & Vaudry, H. Transient expression of somatostatin receptors in the rat visual system during 
development. Dev. Brain Res. 41, 595–606 (1991).
 55. Villena, a, Requena, V., Diaz, F. & Perez de Vargas, I. Histochemical study of RNA content of neurones in the dorsal lateral 
geniculate nucleus during postnatal development. Mech. Ageing Dev. 57, 275–282 (1991).
 56. Stoyanova, I. I., Rutten, W. L. C. & Le Feber, J. Orexin-A and orexin-B during the postnatal development of the rat brain. Cell. Mol. 
Neurobiol. 30, 81–89 (2010).
 57. Yan, J., He, C., Xia, J., Zhang, D. & Hu, Z. Neuroscience Letters Orexin-A excites pyramidal neurons in layer 2 / 3 of the rat 
prefrontal cortex. Neurosci. Lett. 520, 92–97 (2012).
 58. Yu, L., Zhang, X. & Zhang, J. Orexins Excite Neurons of the Rat Cerebellar Nucleus Interpositus Via Orexin 2 Receptors In Vitro. 
88–95 (2010). https://doi.org/10.1007/s12311-009-0146-0
 59. Palus, K., Chrobok, L. & Lewandowski, M. H. Orexins/hypocretins modulate the activity of NPY-positive and -negative neurons 
in the rat intergeniculate leaflet via OX1 and OX2 receptors. Neuroscience 300, 370–380 (2015).
 60. Belle, M. D. C. et al. Acute Suppressive and Long-Term Phase Modulation Actions of Orexin on the Mammalian Circadian Clock. 
J. Neurosci. 34, 3607–3621 (2014).
 61. Ishibashi, M. et al. Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro. 
Peptides 26, 471–481 (2004).
 62. Chen, X. Y., Chen, L. & Du, Y. F. Orexin-A increases the firing activity of hippocampal CA1 neurons through orexin-1 receptors. J. 
Neurosci. Res. 95, 1415–1426 (2017).
 63. Chen, L. et al. Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats. J. 
Neurochem. 147, 380–394 (2018).
 64. Takahashi, K., Koyama, Y., Kayama, Y. & Yamamoto, M. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin. 
Neurosci. 56, 335–336 (2002).
 65. Brown, T. M. et al. Melanopsin contributions to irradiance coding in the thalamo-cortical visual system. PLoS Biol. 8, e1000558 
(2010).
 66. Walmsley, L. et al. Colour As a Signal for Entraining the Mammalian Circadian Clock. PLoS Biol. 13, 1–20 (2015).
 67. Tsuji, T., Tsuji, C., Ludwig, M. & Leng, G. The rat suprachiasmatic nucleus: the master clock ticks at 30 Hz. J. Physiol. 594, 
3629–3650 (2016).
 68. Sakhi, K., Belle, M. D. C., Gossan, N., Delagrange, P. & Piggins, H. D. Daily variation in the electrophysiological activity of mouse 
medial habenula neurones. J. Physiol. 592, 587–603 (2014).
 69. Clement, E. A. et al. Cyclic and sleep-like spontaneous alternations of brain state under urethane anaesthesia. PLoS One 3, (2008).
 70. Pagliardini, S., Gosgnach, S. & Dickson, C. T. Spontaneous Sleep-Like Brain State Alternations and Breathing Characteristics in 
Urethane Anesthetized Mice. PLoS One 8, 1–10 (2013).
 71. Pagliardini, S., Funk, G. D. & Dickson, C. T. Breathing and brain state: Urethane anesthesia as a model for natural sleep. Respir. 
Physiol. Neurobiol. 188, 324–332 (2013).
 72. Zhurakovskaya, E. et al. Global functional connectivity differences between sleep-like states in urethane anesthetized rats measured 
by fMRI. PLoS One 11, 1–12 (2016).
 73. Blasiak, T., Zawadzki, A. & Lewandowski, M. H. Infra-slow oscillation (ISO) of the pupil size of urethane-anaesthetised rats. PLoS 
One 8, e62430 (2013).
 74. Chen, H. et al. Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats. Eur. J. Neurosci. 
44, 2247–2257 (2016).
 75. Takahashi, K. et al. State-dependent effects of orexins on the serotonergic dorsal raphe neurons in the rat. Regul. Pept. 126, 43–47 
(2005).
 76. Hagan, J. J. et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. 96, 10911–10916 
(2002).
 77. Soffin, E. M. et al. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology 42, 127–133 
(2002).
 78. Eriksson, K. S., Sergeeva, Oa, Selbach, O. & Haas, H. L. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to 
tuberomammillary neurons. Eur. J. Neurosci. 19, 1278–1284 (2004).
 79. Brown, R. E., Sergeeva, Oa, Eriksson, K. S. & Haas, H. L. Convergent Excitation of Dorsal Raphe Serotonin Neurons by Multiple 
Arousal Systems (Orexin/Hypocretin, Histamine and Noradrenaline). J. Neurosci. 22, 8850–8859 (2002).
 80. Pekala, D., Blasiak, T., Raastad, M. & Lewandowski, M. H. The influence of orexins on the firing rate and pattern of rat 
intergeniculate leaflet neurons - electrophysiological and immunohistological studies. Eur. J. Neurosci. 34, 1406–1418 (2011).
 81. Klisch, C. et al. Orexin A modulates neuronal activity of the rodent suprachiasmatic nucleus in vitro. Eur. J. Neurosci. 30, 65–75 
(2009).
 82. Brown, T. M., Coogan, A. N., Cutler, D. J., Hughes, A. T. & Piggins, H. D. Electrophysiological actions of orexins on rat 
suprachiasmatic neurons in vitro. Neurosci. Lett. 448, 273–278 (2008).
 83. Apergis-Schoute, J. et al. Optogenetic Evidence for Inhibitory Signaling from Orexin to MCH Neurons via Local Microcircuits. J. 
Neurosci. 35, 5435–5441 (2015).
 84. Mieda, M. et al. Differential Roles of Orexin Receptor-1 and -2 in the Regulation of Non-REM and REM. Sleep. 31, 6518–6526 
(2011).
 85. Riahi, E., Arezoomandan, R., Fatahi, Z. & Haghparast, A. The electrical activity of hippocampal pyramidal neuron is subjected to 
descending control by the brain orexin/hypocretin system. Neurobiol. Learn. Mem. 119, 93–101 (2015).
1 6Scientific RepoRtS |         (2019) 9:16729  | https://doi.org/10.1038/s41598-019-53012-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
 86. Guido, W. Development, form, and function of mouse visual thalamus. J. Neurophysiol. https://doi.org/10.1152/jn.00651.2017 
(2018).
 87. Gut, N. K. & Winn, P. The pedunculopontine tegmental nucleus-A functional hypothesis from the comparative literature. Mov. 
Disord. 31, 615–624 (2016).
 88. Mena-Segovia, J. & Bolam, J. P. Rethinking the Pedunculopontine Nucleus: From Cellular Organization to Function. Neuron 94, 
7–18 (2017).
 89. Marks, G. A. & Roffwarg, H. P. The cholinergic influence upon rat dorsal lateral geniculate nucleus is dependent on state of arousal. 
Brain Res. 494, 294–306 (1989).
 90. Hirsch, J. C., Fourment, a & Marc, M. E. Sleep-related variations of membrane potential in the lateral geniculate body relay neurons 
of the cat. Brain Res. 259, 308–312 (1983).
 91. Steriade, M. & Llinás, R. R. The functional states of the thalamus and the associated neuronal interplay. Physiol. Rev. 68, 649–742 
(1988).
 92. Ramcharan, E. J., Gnadt, J. W. & Sherman, S. M. Higher-order thalamic relays burst more than first-order relays. Proc. Natl. Acad. 
Sci. USA 102, 12236–41 (2005).
 93. Ramcharan, E. J., Gnadt, J. W. & Sherman, S. M. Burst and tonic firing in thalamic cells of unanesthetized, behaving monkeys. Vis. 
Neurosci. 17, 55–62 (2000).
 94. Wörgötter, F., Eyding, D., Macklis, J. D. & Funke, K. The influence of the corticothalamic projection on responses in thalamus and 
cortex. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 357, 1823–1834 (2002).
 95. De Labra, C. et al. Changes in visual responses in the feline dLGN: Selective thalamic suppression induced by transcranial magnetic 
stimulation of V1. Cereb. Cortex 17, 1376–1385 (2007).
 96. Espinosa, N., Mariño, J., de Labra, C. & Cudeiro, J. Cortical modulation of the transient visual response at thalamic level: A TMS 
study. PLoS One 6, (2011).
 97. Hasse, J. M. & Briggs, F. Corticogeniculate feedback sharpens the temporal precision and spatial resolution of visual signals in the 
ferret. Proc. Natl. Acad. Sci. 2017, 04524, https://doi.org/10.1073/pnas.1704524114 (2017).
 98. Li, B., Funke, K., Wörgötter, F. & Eysel, U. T. Correlated variations in EEG pattern and visual responsiveness of cat lateral geniculate 
relay cells. J. Physiol. 514, 857–874 (1999).
 99. Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE 
guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).
 100. Paxinos, G. & Watson, C. The rat brain in stereotaxic coordinates. (Elsevier, 2007).
 101. Cerina, M. et al. Thalamic K v 7 channels: pharmacological properties and activity control during noxious signal processing. 
https://doi.org/10.1111/bph.13113 (2015).
 102. Howarth, M., Walmsley, L. & Brown, T. M. Binocular integration in the mouse lateral geniculate nuclei. Curr. Biol. 24, 1241–7 
(2014).
 103. Grieve, K. L. Binocular visual responses in cells of the rat dLGN. J. Physiol. 566, 119–124 (2005).
 104. Young, E. D., Robert, J.-M. & Shofner, W. P. Regularity and latency of units in ventral cochlear nucleus: implications for unit 
classification and generation of response properties. J. Neurophysiol. 60, 1–29 (1988).
 105. Orlowska-Feuer, P., Allen, A. E., Storchi, R., Szkudlarek, H. J. & Lewandowski, M. H. The contribution of inner and outer retinal 
photoreceptors to infra-slow oscillations in the rat olivary pretectal nucleus. Eur. J. Neurosci. 43, 823–833 (2016).
Acknowledgements
We are grateful to Anna Blasiak, PhD (Jagiellonian University) for fruitful discussions during the data collection 
and Jaime Matos for his technical help on some of in vivo experiments. This study was financially supported by 
National Science Centre Grant No. 2013/09/B/NZ4/000541 and Institute of Zoology and Biomedical Research, 
Jagiellonian University in Krakow grant No. K/ZDS/008069.
Author contributions
P.O.-.F., M.H.L. conceived the project. P.O.-.F., M.K.S. designed the experiments. P.O.-.F., M.K.S., K.D. performed 
in vivo experiments. P.O.-F. analysed in vivo data. K.P.-C. performed and analysed in vitro experiments. P.O.-F. 
with the help from M.K.S. wrote the manuscript. All authors have read and approved the final version of this 
manuscript and agreed to be accountable for all aspects of the work ensuring that questions related to the 
accuracy or integrity of any part of the work are appropriately investigated and resolved. All persons designated 
as authors qualify for authorship, and all those who qualify for authorship are listed.
competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41598-019-53012-9.
Correspondence and requests for materials should be addressed to P.O.-F. or M.H.L.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
